Trade Summary

Today, Bisaro Paul, serving as Dir at Myriad Genetics Inc (MYGN), purchased 7,500 shares at $3.69 per share, for a total transaction value of $27,638.00. Following this transaction, Bisaro Paul now holds 97,441 shares of MYGN.

This purchase represents a 8.00% increase in Bisaro Paul's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 5:16 PM ET, meaning the disclosure happened on the same day as the trade.

Myriad Genetics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.